An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder

An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder

Abstract Background Despite the current treatments available for panic disorder (PD), as many as one-third of patients have persistent and treatment-resistant panic attacks. Vortioxetine is an approved medicine for major depressive disorder and has been shown to have anxiolytic properties. The purpo...

Full description

Bibliographic Details
Main Authors: Anish Shah, Joanne Northcutt
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Annals of General Psychiatry
Subjects:
Panic disorder
Vortioxetine
Anxiety
Agoraphobia
Depression
Online Access:http://link.springer.com/article/10.1186/s12991-018-0190-6

Internet

http://link.springer.com/article/10.1186/s12991-018-0190-6

Similar Items